ABBV: RAPP EDWARD J discloses securities transactions

By AlphaYouPublished Oct 2, 2026Form 4

Stocks in this disclosure

Reported activity

RAPP EDWARD J

Reporting filer

RAPP EDWARD J reported Grant or award in AbbVie Inc.: 129 units of Stock Equivalent Units (derivative), dated 2026-09-30. The full Form 4 contains 1 transaction entry.

Disclosed: Oct 2, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Stock Equivalent Units (derivative)	RAPP EDWARD J	2026-09-30	A	Grant or award	129	261.59	29,568	2 days	Filed terms security Title: Stock Equivalent Units conversion Or Exercise Price: 261.59 transaction Date: 2026-09-30 transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Shares: 129 transaction Price Per Share: 261.59 transaction Acquired Disposed Code: A id: F1 id: F1 underlying Security Title: Common Stock underlying Security Shares: 129 shares Owned Following Transaction: 29568 id: F2 direct Or Indirect Ownership: D nature Of Ownership:

Stock Equivalent Units (derivative)

Owner: RAPP EDWARD J
Date: 2026-09-30
Code: A
Action: Grant or award
Quantity: 129
Price: 261.59
Following holdings: 29,568
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Stock Equivalent Units
conversion Or Exercise Price: 261.59
transaction Date: 2026-09-30
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 129
transaction Price Per Share: 261.59
transaction Acquired Disposed Code: A
id: F1
id: F1
underlying Security Title: Common Stock
underlying Security Shares: 129
shares Owned Following Transaction: 29568
id: F2
direct Or Indirect Ownership: D
nature Of Ownership:

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
RAPP EDWARD J: Director.
F1: Director fees credited to a stock equivalent unit account under the director's grantor trust are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock.
F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Stock Equivalent Units (derivative)

RAPP EDWARD J

2026-09-30

Grant or award

129

261.59

29,568

2 days

Filed terms

security Title: Stock Equivalent Units
conversion Or Exercise Price: 261.59
transaction Date: 2026-09-30
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 129
transaction Price Per Share: 261.59
transaction Acquired Disposed Code: A
id: F1
id: F1
underlying Security Title: Common Stock
underlying Security Shares: 129
shares Owned Following Transaction: 29568
id: F2
direct Or Indirect Ownership: D
nature Of Ownership:

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

RAPP EDWARD J: Director.

F1: Director fees credited to a stock equivalent unit account under the director's grantor trust are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock.

F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.